Internal Medicine, Pulmonary Disease · Ponce, PR
NPI
1003850397
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
917 Ave Tito Castro, Torre Medica San Lucas Suite 701
Ponce, PR, 00716
Phone (787) 290-5577
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
474 services
Medicare patients, 2024
162
Average age 72
Drug cost, 2024
$6.0M
6,000 prescriptions
Company payments, 2025
$2,454
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George P Fahed was code 94660 (treatment - miscellaneous), 145 times for 96 patients. In total George P Fahed billed 474 services in 17 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 94660 Treatment - Miscellaneous | Office | 145 | 96 | $42.32 | $6,136 |
| 99213 Office E&M - Established | Office | 117 | 75 | $62.17 | $7,274 |
| 94375 Pulmonary Function Testing | Office | 28 | 28 | $27.72 | $776 |
| 94729 Pulmonary Function Testing | Office | 26 | 26 | $40.17 | $1,044 |
| 94726 Pulmonary Function Testing | Office | 26 | 26 | $38.91 | $1,012 |
| 94618 Pulmonary Function Testing | Office | 25 | 25 | $26.38 | $660 |
| 95811 Sleep Study | Office | 23 | 22 | $508.94 | $12K |
| 99212 Office E&M - Established | Office | 18 | 16 | $38.76 | $698 |
| 99203 Office E&M - New | Office | 16 | 16 | $72.09 | $1,153 |
| 99202 Office E&M - New | Office | 15 | 15 | $47.95 | $719 |
By year: 2022 $39K for 541 services; 2023 $38K for 522 services; 2024 $34K for 474 services.
Medicare prescription drug claims, 2024
In 2024, the drug George P Fahed prescribed most often to Medicare patients was Fluticasone Propionate, with 1,195 prescriptions and refills. In total George P Fahed wrote 6,000 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 1,195 | 1,423 | 431 | $23K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 841 | 1,336 | 287 | $37K |
| Dexamethasone Generic | 653 | 653 | 347 | $22K |
| Adempas Riociguat | 261 | 261 | 28 | $3.6M |
| Theophylline Er Theophylline Anhydrous | 253 | 273 | 96 | $18K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 212 | 222 | 44 | $105K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 135 | 136 | 31 | $90K |
| Azelastine Hcl Generic | 108 | 170 | 45 | $2,769 |
| Spiriva Respimat Tiotropium Bromide | 104 | 105 | 22 | $55K |
| Montelukast Sodium Generic | 94 | 117 | 30 | $865 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 93 | 104 | 31 | $12K |
| Azithromycin Generic | 92 | 93 | 86 | $719 |
| Breo Ellipta Fluticasone/Vilanterol | 88 | 93 | 21 | $38K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 88 | 98 | 29 | $21K |
| Famotidine Generic | 78 | 82 | 25 | $609 |
Brand drugs: - claims; generic drugs: 3,653 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George P Fahed $2,454 ($2,454 in general payments such as food, travel and fees) from 11 companies. The largest payer was Jazz Pharmaceuticals Inc. with $724.
| Company | Payments | Amount |
|---|---|---|
| Jazz Pharmaceuticals Inc. JAZZ | 12 | $724 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $523 |
| Merck Sharp & Dohme LLC MRK | 4 | $309 |
| GlaxoSmithKline, LLC. GSK | 5 | $278 |
| United Therapeutics Corporation UTHR | 5 | $247 |
| Harmony Biosciences LLC HRMY | 4 | $173 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $64.99 |
| Viatris Specialty LLC | 2 | $55.4 |
| Medtronic, Inc. MDT | 1 | $33.34 |
| Genzyme Corporation SNY | 1 | $26.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.